| MeSH term | MeSH ID | Detail |
|---|---|---|
| Osteoblastoma | D018215 | 1 associated lipids |
| Erythromelalgia | D004916 | 1 associated lipids |
| Fibromuscular Dysplasia | D005352 | 2 associated lipids |
| Atrial Premature Complexes | D018880 | 1 associated lipids |
| Latex Hypersensitivity | D020315 | 1 associated lipids |
| Drowning | D004332 | 2 associated lipids |
| Jejunal Diseases | D007579 | 3 associated lipids |
| Basal Ganglia Hemorrhage | D020145 | 1 associated lipids |
| Radiculopathy | D011843 | 1 associated lipids |
| Intracranial Hemorrhage, Hypertensive | D020299 | 1 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Gonçalves LH et al. | Acetylsalicylic acid therapy: influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels. | 2014 | Clin. Chim. Acta | pmid:24316050 |
| Chetty N and Naran NH | Platelet hyperreactivity in hyperlipidaemia with specific reference to platelet lipids and fatty acid composition. | 1992 | Clin. Chim. Acta | pmid:1477981 |
| Gonçalves LH et al. | Urinary 11-dehydro thromboxane B₂ levels in type 2 diabetic patients before and during aspirin intake. | 2011 | Clin. Chim. Acta | pmid:21510926 |
| Barnett AH et al. | Circulating prostanoid levels, both basal and during the chlorpropamide alcohol flush, in non-insulin dependent diabetes. | 1981 | Clin. Endocrinol. (Oxf) | pmid:6895721 |
| Karamouzis I et al. | Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome. | 2015 | Clin. Endocrinol. (Oxf) | pmid:24923553 |
| Williams WR et al. | Aspirin-like effects of selected food additives and industrial sensitizing agents. | 1989 | Clin. Exp. Allergy | pmid:2507097 |
| Barbara J et al. | Inhaled cornstarch glove powder increases latex-induced airway hyper-sensitivity in guinea-pigs. | 2004 | Clin. Exp. Allergy | pmid:15196289 |
| Pujol JL et al. | Substance P activation of bronchoalveolar macrophages from asthmatic patients and normal subjects. | 1989 | Clin. Exp. Allergy | pmid:2480840 |
| Oosaki R et al. | Correlation among urinary eosinophil protein X, leukotriene E4, and 11-dehydrothromboxane B2 in patients with spontaneous asthmatic attack. | 1998 | Clin. Exp. Allergy | pmid:9761018 |
| Somova L and Mufunda J | Platelet activity and salt sensitivity in the pathogenesis of systemic (essential) hypertension in black Africans. | 1993 | Clin. Exp. Hypertens. | pmid:8401415 |
| Fuller RW et al. | Immunoglobulin E-dependent stimulation of human alveolar macrophages: significance in type 1 hypersensitivity. | 1986 | Clin. Exp. Immunol. | pmid:2947765 |
| Vicenzi E et al. | Human mononuclear phagocytes from different anatomical sites differ in their capacity to metabolize arachidonic acid. | 1984 | Clin. Exp. Immunol. | pmid:6432383 |
| Hartung HP et al. | Release of prostaglandin E and thromboxane from macrophages by stimulation with factor H. | 1984 | Clin. Exp. Immunol. | pmid:6234114 |
| Moosig F et al. | Opsonization of apoptotic neutrophils by anti-neutrophil cytoplasmic antibodies (ANCA) leads to enhanced uptake by macrophages and increased release of tumour necrosis factor-alpha (TNF-alpha). | 2000 | Clin. Exp. Immunol. | pmid:11122261 |
| Hui SC et al. | Arachidonic acid metabolism in nicotine-treated rats and nicotine-incubated rabbit aortic smooth muscle cells. | 1992 | Clin. Exp. Pharmacol. Physiol. | pmid:1424297 |
| Sturm M et al. | The measurement of plasma thromboxane B2 and the effect of smoking. | 1984 Nov-Dec | Clin. Exp. Pharmacol. Physiol. | pmid:6536421 |
| Anfossi G et al. | Calcium-channel blocking agents verapamil and diltiazem are inhibitors of vasopressin-induced human platelet activation. | 1991 | Clin. Exp. Pharmacol. Physiol. | pmid:1782723 |
| Kanamori S et al. | Effects of dietary fibre on dimethylhydrazine-induced changes in prostanoid concentrations in rat colonic mucosa. | 1995 | Clin. Exp. Pharmacol. Physiol. | pmid:8575110 |
| Anfossi G et al. | Effect of labetalol on human platelet function. | 1988 | Clin. Exp. Pharmacol. Physiol. | pmid:2856060 |
| Yin K et al. | Effect of pure eicosapentaenoic acid feeding on blood pressure and vascular reactivity in spontaneously hypertensive rats. | 1988 | Clin. Exp. Pharmacol. Physiol. | pmid:2856054 |
| Boura AL and Murphy RD | Thromboxane B2 inhibits prostaglandin E2 inactivation by the rat isolated perfused lung. | 1978 Jul-Aug | Clin. Exp. Pharmacol. Physiol. | pmid:699382 |
| Wang LH et al. | Effect of heparin on activation of platelet function in patients during radiofrequency catheter ablation. | 2006 Jan-Feb | Clin. Exp. Pharmacol. Physiol. | pmid:16445701 |
| Voisin V et al. | Protection of Wistar-Furth rats against postischaemic acute renal injury: role for nitric oxide and thromboxane? | 2014 | Clin. Exp. Pharmacol. Physiol. | pmid:25115485 |
| Croft KD et al. | Effect of dietary fish oils on the formation of leukotriene B4 and B5, thromboxane and platelet activating factor by rat leukocytes. | 1988 | Clin. Exp. Pharmacol. Physiol. | pmid:2856061 |
| Aslam R et al. | Lipoproteins inhibit platelet aggregation and arachidonic acid metabolism in experimental hypercholesterolaemia. | 2008 | Clin. Exp. Pharmacol. Physiol. | pmid:18215184 |
| Taylor RR et al. | Whole blood platelet aggregation is not affected by cigarette smoking but is sex-related. | 1987 | Clin. Exp. Pharmacol. Physiol. | pmid:3440324 |
| Fagan SC et al. | Prostanoid concentrations in human CSF following acute ischaemic brain infarction. | 1986 | Clin. Exp. Pharmacol. Physiol. | pmid:3791712 |
| Sheu JR et al. | Inhibitory mechanisms of naloxone on human platelets. | 1998 Jul-Aug | Clin. Exp. Pharmacol. Physiol. | pmid:9673433 |
| Komers R et al. | Cyclo-oxygenase-2 inhibition attenuates the progression of nephropathy in uninephrectomized diabetic rats. | 2007 Jan-Feb | Clin. Exp. Pharmacol. Physiol. | pmid:17201733 |
| Codde JP et al. | Can the synthesis of platelet-activating factor, a potent vasodilator and pro-aggregatory agent, be altered by dietary marine oils? | 1987 | Clin. Exp. Pharmacol. Physiol. | pmid:2822306 |
| Codde JP et al. | Dietary suppression of prostaglandin synthesis does not accelerate DOCA/salt hypertension in rats. | 1987 | Clin. Exp. Pharmacol. Physiol. | pmid:3315335 |
| Zhang BL et al. | Effects of naftidrofuryl on isolated perfused kidneys of spontaneously hypertensive rats. | 1993 | Clin. Exp. Pharmacol. Physiol. | pmid:8261661 |
| Sugimoto KI et al. | Delayed hypotensive effect of the thromboxane A2/prostaglandin H2 receptor antagonist S-1452 in spontaneously hypertensive rats. | 2000 | Clin. Exp. Pharmacol. Physiol. | pmid:10901388 |
| Krieger J et al. | Urinary excretion of prostanoids during sleep in obstructive sleep apnoea patients. | 1991 | Clin. Exp. Pharmacol. Physiol. | pmid:1914253 |
| Hoshino H et al. | Mechanism and prevention of chronic colonic inflammation with trinitrobenzene sulfonic acid in rats. | 1992 | Clin. Exp. Pharmacol. Physiol. | pmid:1424301 |
| Sturm MJ et al. | Whole blood aggregation and plasma lyso-PAF related to smoking and atherosclerosis. | 1989 | Clin. Exp. Pharmacol. Physiol. | pmid:2805433 |
| Croft KD et al. | The effect of dietary fish oil and long-term salt loading on blood pressure and eicosanoid metabolism in spontaneously hypertensive rats. | 1988 | Clin. Exp. Pharmacol. Physiol. | pmid:3271614 |
| Dionne RA et al. | Analgesia and COX-2 inhibition. | 2001 Nov-Dec | Clin. Exp. Rheumatol. | pmid:11695255 |
| Rilantono LI et al. | Dietary antioxidative potential in arteries. | 2000 | Clin. Hemorheol. Microcirc. | pmid:11321428 |
| Renz H et al. | Tumor necrosis factor-alpha, interleukin 1, eicosanoid, and hydrogen peroxide release from macrophages exposed to glove starch particles. | 1993 | Clin. Immunol. Immunopathol. | pmid:8513589 |
| Kelley VE et al. | Effect of ibuprofen, a fatty acid cyclooxygenase inhibitor, on murine lupus. | 1982 | Clin. Immunol. Immunopathol. | pmid:6819912 |
| Sadilkova L et al. | The purification step is not crucial in EIA measurements of thromboxane B2 and 11-dehydrothromboxane B2 in human plasma. | 2012 | Clin. Lab. | pmid:22372363 |
| Niwa T et al. | Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome. | 1988 | Clin. Nephrol. | pmid:3214971 |
| Ylikorkala O et al. | Prostacyclin and thromboxane in chronic uremia: effect of hemodialysis. | 1982 | Clin. Nephrol. | pmid:6754193 |
| Clark WF et al. | The effects of a thromboxane synthase inhibitor, a prostacyclin analog and PGE1 on the nephritis of the NZB/W F1 mouse. | 1987 | Clin. Nephrol. | pmid:2450713 |
| Matsumoto H and Nakao T | Elevated urinary excretion of thromboxane B2 in adults with minimal-change nephrotic syndrome. | 2000 | Clin. Nephrol. | pmid:10661487 |
| Clark WF et al. | Comparative efficacy of dietary treatments on renal function in rats with sub-total nephrectomy: renal polyunsaturated fatty acid incorporation and prostaglandin excretion. | 1990 | Clin. Nephrol. | pmid:2302867 |
| Fagugli RM et al. | Reduction of renal functional reserve in kidney transplant recipients: a possible role of arachidonic acid metabolism alterations. | 1998 | Clin. Nephrol. | pmid:9696430 |
| Bloom A et al. | Hemolytic-uremic syndrome: demonstration of abnormalities of platelet reactivity and insensitivity to prostaglandin I2. | 1985 | Clin. Nephrol. | pmid:3886228 |
| Cantaro S et al. | Urinary excretion of vasoactive substances in chronic renal failure. | 2001 | Clin. Nephrol. | pmid:11393385 |
| Kanai H et al. | Serotonin metabolism in patients undergoing hemodialysis. | 1996 | Clin. Nephrol. | pmid:8861800 |
| Ohnishi A et al. | Effects of a sustained thromboxane synthase inhibition on exercise-induced changes in eicosanoid formation, catecholamine concentration, and platelet aggregation in humans. | 1992 | Clin. Pharmacol. Ther. | pmid:1563215 |
| Nüsing RM et al. | Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide. | 2001 | Clin. Pharmacol. Ther. | pmid:11673754 |
| Hussein Z et al. | Characterization of the pharmacokinetics and pharmacodynamics of a new oral thromboxane A2-receptor antagonist AA-2414 in normal subjects: population analysis. | 1994 | Clin. Pharmacol. Ther. | pmid:8162671 |
| Sciulli MG et al. | Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease. | 2006 | Clin. Pharmacol. Ther. | pmid:16890573 |
| Cibattoni G et al. | Effects of sulindac on renal and extrarenal eicosanoid synthesis. | 1987 | Clin. Pharmacol. Ther. | pmid:3549118 |
| FitzGerald GA and Oates JA | Selective and nonselective inhibition of thromboxane formation. | 1984 | Clin. Pharmacol. Ther. | pmid:6370554 |
| Tegeder I et al. | Comparison of inhibitory effects of meloxicam and diclofenac on human thromboxane biosynthesis after single doses and at steady state. | 1999 | Clin. Pharmacol. Ther. | pmid:10340919 |
| Renda G et al. | Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. | 2006 | Clin. Pharmacol. Ther. | pmid:16952493 |
| Luderer JR et al. | Dazoxiben, a thromboxane synthetase inhibitor, in Raynaud's phenomenon. | 1984 | Clin. Pharmacol. Ther. | pmid:6428793 |
| Graham RM et al. | Effects of short-term beta blockade on blood pressure, plasma thromboxane B2, and plasma and urinary prostaglandins E2 and F2 alpha in normal subjects. | 1982 | Clin. Pharmacol. Ther. | pmid:6120775 |
| Wagner B et al. | Effect of ritanserin, a 5-hydroxytryptamine2-receptor antagonist, on platelet function and thrombin generation at the site of plug formation in vivo. | 1990 | Clin. Pharmacol. Ther. | pmid:2146058 |
| Sedor JR et al. | Effects of sulindac and indomethacin on renal prostaglandin synthesis. | 1984 | Clin. Pharmacol. Ther. | pmid:6428794 |
| Ylitalo P et al. | Inhibition of prostaglandin synthesis by indomethacin interacts with the antihypertensive effect of atenolol. | 1985 | Clin. Pharmacol. Ther. | pmid:3899459 |
| Perini JA et al. | Influence of CYP2C9 genotypes on the pharmacokinetics and pharmacodynamics of piroxicam. | 2005 | Clin. Pharmacol. Ther. | pmid:16198655 |
| Chouinard ML et al. | Pharmacokinetics and biochemical efficacy of pirmagrel, a thromboxane synthase inhibitor, in renal allograft recipients. | 1992 | Clin. Pharmacol. Ther. | pmid:1458769 |
| Lee CR et al. | Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study. | 2008 | Clin. Pharmacol. Ther. | pmid:17495879 |
| Longenecker GL et al. | Kinetics of ibuprofen effect on platelet and endothelial prostanoid release. | 1985 | Clin. Pharmacol. Ther. | pmid:3882308 |
| Loew D et al. | Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo. | 2001 | Clin. Pharmacol. Ther. | pmid:11372004 |
| Levy M et al. | Cerebrospinal fluid prostaglandins after systemic dipyrone intake. | 1998 | Clin. Pharmacol. Ther. | pmid:9695726 |
| Wilson TW | Responses to furosemide in normotensive and hypertensive subjects. | 1983 | Clin. Pharmacol. Ther. | pmid:6688772 |
| Gordon SM et al. | Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury model. | 2002 | Clin. Pharmacol. Ther. | pmid:12189364 |
| Khan AA et al. | In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model. | 2002 | Clin. Pharmacol. Ther. | pmid:12152003 |
| Kirchheiner J et al. | Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2. | 2002 | Clin. Pharmacol. Ther. | pmid:12152005 |
| Pedersen AK and FitzGerald GA | Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing. | 1985 | Clin. Pharmacol. Ther. | pmid:3917387 |
| Sabha M et al. | Transdermal nicotine mimics the smoking-induced endothelial dysfunction. | 2000 | Clin. Pharmacol. Ther. | pmid:10976548 |
| Skarke C et al. | Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649. | 2012 | Clin. Pharmacol. Ther. | pmid:22278334 |
| Cipollone F et al. | Effects of nabumetone on prostanoid biosynthesis in humans. | 1995 | Clin. Pharmacol. Ther. | pmid:7554708 |
| de Meijer A et al. | Meloxicam, 15 mg/day, spares platelet function in healthy volunteers. | 1999 | Clin. Pharmacol. Ther. | pmid:10546927 |
| Cerletti C et al. | Pharmacokinetics of enteric-coated aspirin and inhibition of platelet thromboxane A2 and vascular prostacyclin generation in humans. | 1987 | Clin. Pharmacol. Ther. | pmid:3301151 |
| Reines HD et al. | Dazoxiben in human sepsis and adult respiratory distress syndrome. | 1985 | Clin. Pharmacol. Ther. | pmid:3979000 |
| Halushka MK et al. | Genetic variation in cyclooxygenase 1: effects on response to aspirin. | 2003 | Clin. Pharmacol. Ther. | pmid:12545150 |
| Blöchl-Daum B et al. | Effects of cisplatin on urinary thromboxane B2 excretion. | 1995 | Clin. Pharmacol. Ther. | pmid:7586934 |
| Docherty JC and Wilson TW | Effect of indomethacin on arachidonic acid metabolism in human leukocytes stimulated ex vivo. | 1991 | Clin. Pharmacol. Ther. | pmid:1848800 |
| Roberts DG et al. | Sulindac is not renal sparing in man. | 1985 | Clin. Pharmacol. Ther. | pmid:4028619 |
| Laustiola K et al. | Gemfibrozil decreases platelet reactivity in patients with hypercholesterolemia during physical stress. | 1988 | Clin. Pharmacol. Ther. | pmid:3278823 |
| Cremer KF et al. | Effects of diltiazem, dipyridamole, and their combination on hemostasis. | 1984 | Clin. Pharmacol. Ther. | pmid:6435926 |
| Conti P et al. | Enhanced thromboxane synthesis and vacuolization in human polymorphonuclear leucocytes induced by human lymphokine containing supernatants. | 1985 | Clin. Rheumatol. | pmid:3879473 |
| Laitinen O et al. | Plasma levels and urinary excretion of prostaglandins in patients with rheumatoid arthritis. | 1983 | Clin. Rheumatol. | pmid:6589104 |
| Wennmalm A et al. | Non-invasive assessment of the cardiovascular eicosanoids, thromboxane A2 and prostacyclin, in randomly sampled males, with special reference to the influence of inheritance and environmental factors. | 1990 | Clin. Sci. | pmid:2176952 |
| Rathaus M et al. | Altered prostaglandin synthesis and impaired sodium conservation in the kidneys of old rats. | 1992 | Clin. Sci. | pmid:1327646 |
| Johnston C et al. | Prostacyclin and thromboxane in non-insulin dependent diabetes: the chlorpropamide alcohol flush reaction revisited. | 1984 | Clin. Sci. | pmid:6548428 |
| Kramer HJ et al. | Impaired renal function in obstructive jaundice: enhanced glomerular thromboxane synthesis and effects of thromboxane receptor blockade in bile duct-ligated rats. | 1995 | Clin. Sci. | pmid:7704998 |
| Wilson KM et al. | Effect of aspirin infusions on platelet function in humans. | 1990 | Clin. Sci. | pmid:2167788 |
| Basu S et al. | Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. | 2000 | Clin. Sci. | pmid:11099394 |
| Cumming AD et al. | Acute effect of a thromboxane synthetase inhibitor on renal function in unanaesthetized sheep. | 1987 | Clin. Sci. | pmid:3308284 |
| Best LC et al. | The relationship between the production of thromboxane B2 and malondialdehyde by human blood platelets. | 1980 | Clin. Sci. | pmid:7190885 |
| Geertsen PF et al. | Renal haemodynamics, sodium and water reabsorption during continuous intravenous infusion of recombinant interleukin-2. | 1998 | Clin. Sci. | pmid:9662488 |
| RÃ¥ngemark C and Wennmalm A | Cigarette smoking and urinary excretion of markers for platelet/vessel wall interaction in healthy women. | 1991 | Clin. Sci. | pmid:1649717 |
| Förstermann U and Feuerstein TJ | Decreased systemic formation of prostaglandin E and prostacyclin, and unchanged thromboxane formation, in alcoholics during withdrawal as estimated from metabolites in urine. | 1987 | Clin. Sci. | pmid:3308287 |